OTTAWA, December 6, 2011 (LifeSiteNews.com) – In June Health Canada announced that it would be reviewing the safety of the contraceptive pills Yaz and Yasmin over concerns users may experience a two to three times greater risk of developing blood clots, compared to those who use other brands of contraceptive pills.
The results of the review, released December 5, state that “drospirenone-containing oral contraceptives (marketed under the brand names Yasmin and Yaz) … may be associated with a risk of blood clots that is 1.5 to 3 times higher than other birth control pills.”….
